Full Research Kit Catalog

GLP-1 receptor agonist studied in appetite-regulation, caloric-intake and metabolic research models.

Dual GIP/GLP-1 receptor agonist studied in appetite-regulation, insulin-signaling and metabolic research models.

Triple GLP-1/GIP/glucagon receptor agonist under active study in metabolic and energy-expenditure research models.

Modified HGH fragment (176-191) studied in lipolysis and fat-metabolism research models without IGF-1 signaling.

Amylin/GLP-1 combination studied in appetite-regulation and metabolic research models.

Mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and exercise adaptation.

Body protective compound studied for tendon/ligament healing, gut repair, and systemic tissue recovery.

Thymosin Beta-4 fragment studied for muscle recovery, angiogenesis promotion, and reduced inflammation.

BPC-157 and TB-500 in one vial, studied together in tissue-repair and recovery research models.

Copper-binding tripeptide studied for wound healing, collagen synthesis, skin regeneration, and anti-inflammatory effects.

Long-acting IGF-1 analog studied for muscle cell proliferation, nutrient uptake, and lean tissue development.

ACTH(4-7) analog studied in neuroprotection, BDNF-signaling and cognition research models.

Nicotinamide adenine dinucleotide, the redox coenzyme studied in cellular energy-metabolism, sirtuin and DNA-repair research.

Three-peptide research blend — GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg) per vial — studied in skin-biology, collagen-synthesis and matrix-remodeling research models.

Sterile water with 0.9% benzyl alcohol for multi-dose peptide reconstitution.

Small-molecule NNMT inhibitor studied in adipocyte, NAD+ salvage and metabolic research models.

GHRH analog studied in growth-hormone pulse and visceral-adiposity research models.

Alpha-MSH-derived tripeptide studied for anti-inflammatory, wound healing, and gut protection properties.

Mitochondria-targeting peptide studied for cellular energy restoration and oxidative stress reduction.

Long-acting GHRH analog with Drug Affinity Complex for extended GH stimulation.

Selective GHRP studied for clean GH pulse stimulation with minimal cortisol or prolactin elevation.

GHRH(1-29) analog studied for endogenous GH secretion, sleep quality, and body composition.

Myostatin inhibitor studied for muscle fiber development, body composition, and regenerative support.

Tuftsin-derived peptide studied in anxiolytic, stress-response and memory research models.

Delta sleep-inducing peptide studied for sleep architecture, stress resilience, and neuroendocrine support.

Alpha-MSH analog studied for melanogenesis stimulation and pigmentation research.

Cyclic alpha-MSH analog studied for melanocortin-receptor activation and pigmentation research.

Four-peptide research blend — BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg) and KPV (10mg) per vial — studied in tissue-repair, inflammation and skin-biology research models.